Area of Research: Combination Therapy
2022 Grant Recipients
- Haineng Xu, PhD, University of Pennsylvania Early Career Investigator GrantStrategies to Exploit Genetic Alterations in Clear-Cell Ovarian Cancer
2020 Grant Recipients
- Nidhi Sahni, PhD, MD Anderson Cancer Center Early Career Investigator GrantSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
- James Duncan, PhD, Fox Chase Cancer Center Early Career Investigator GrantExploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
2019 Grant Recipients
- Shariska Petersen, MD, University of Kansas Medical Center Research Institute Mentored Investigator GrantCyclin E and BRD4 as Markers for a New PARPi Drug Combination
- Shuai Wu, PhD, The Wistar Institute Mentored Investigator GrantSynthetic Lethality for ARID1A Mutation in Ovarian Cancer
2018 Grant Recipients
- Gordon Mills, MD, PhD, MD Anderson Cancer Center Collaborative Research Development GrantRational Combination Therapy in Ovarian Cancer
2017 Grant Recipients
- Ronald Chandler, PhD, Michigan State University Early Career Investigator GrantIntegrated Roles of Epigenetics and Cell Signaling in Ovarian Cancer
2015 Grant Recipients
- Bob McGray, PhD, Roswell Park Cancer Institute Mentored Investigator GrantCombination Oncolytic Virotherapy/ACT for Ovarian Cancer Treatment
- Sarah Adams, MD, University of New Mexico Early Career Investigator GrantA Combination Therapy for Hereditary Ovarian Cancer
- Kris Wood, PhD, Duke University Early Career Investigator GrantDefining New Combination Therapies for High-grade Serous Ovarian Cancer
2014 Grant Recipients
- Ursula Matulonis, MD, Dana Farber Cancer Institute Collaborative Research Development GrantRational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
2012 Grant Recipients
- See-Hyoung Park, PhD, Stanford University Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
- Sarah Adams, MD, University of Pennsylvania Early Career Investigator GrantDevelopment of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
2005 Grant Recipients
- Andrew Li, MD, Cedars-Sinai Medical Center Early Career Investigator GrantTesting Medications for Other Conditions to Treat Ovarian Cancer
2003 Grant Recipients
- Parameshwar Mahareshti, DVM, University of Alabama - Birmingham Individual Investigator AwardA New Combination Drug Treatment for Ovarian Cancer
2000 Grant Recipients
- Wei Hu, MD, PhD, MD Anderson Cancer Center Individual Investigator AwardEffects of a Novel Combination Drug Treatment on Cell Lines Derived from Human Ovarian Cancer